Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023

Rhea-AI Summary

Harvard Bioscience (Nasdaq: HBIO) announced that Jim Green, Chairman and CEO, will present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023, at 9:45 AM ET. A live webcast of the presentation will be available online and archived on the company's Investor Relations webpage for a limited time. Additionally, virtual one-on-one meetings will be hosted on the same day for interested investors. Harvard Bioscience specializes in developing, manufacturing, and selling technologies for life science applications, serving clients worldwide, including top academic institutions and pharmaceutical companies.

HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023.

Mr. Green will present on Tuesday, March 21 at 9:45 AM ET. A live webcast of the presentation will be available here. The presentation will also be archived on the Investor Relations section of the Harvard Bioscience website for a limited period of time.

Harvard Bioscience will also host virtual one-on-one meetings with investors on Tuesday, March 21, 2023.

To register for the presentation or to schedule a one-on-one meeting, please visit www.key.com/lsmt.

About Harvard Bioscience

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.

For more information, please visit our website at www.harvardbioscience.com.

Investor Contact:

Harvard Bioscience, Inc.
Investor Relations
(508) 893-3120
investors@harvardbioscience.com

FAQ

When will Harvard Bioscience present at the KeyBanc Capital Markets Investor Forum?

Harvard Bioscience will present on March 21, 2023, at 9:45 AM ET.

Where can I watch the Harvard Bioscience presentation?

The presentation will be available via live webcast and archived on the Investor Relations section of the Harvard Bioscience website.

Is Harvard Bioscience hosting one-on-one meetings with investors?

Yes, Harvard Bioscience will host virtual one-on-one meetings with investors on March 21, 2023.

What is the stock symbol for Harvard Bioscience?

The stock symbol for Harvard Bioscience is HBIO.

Who is presenting for Harvard Bioscience at the investor forum?

Jim Green, Chairman and CEO of Harvard Bioscience, will present at the investor forum.